dorsaVi

dorsaVi Equity

The The Equity of dorsaVi (DVL.AX) as of Sep 26, 2026 is 2.84 M AUD. In the previous year, The Equity was 1.02 M AUD — a change of 177.22% (higher).

Equity

2.84 MAUD

YoY

177.22%

Last updated:

In 2026, dorsaVi's equity was 2.84 M AUD, a 177.22% increase from the 1.02 M AUD equity in the previous year.

The dorsaVi Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
9.42 M AUD
Jan 1, 2019
6.99 M AUD
Jan 1, 2020
459,000.00 AUD
Jan 1, 2021
2.48 M AUD
Jan 1, 2022
1.22 M AUD
Jan 1, 2023
1.68 M AUD
Jan 1, 2024
1.02 M AUD
Jan 1, 2025
2.84 M AUD
The dorsaVi Equity history
YEAREquityYoY
2.84 MAUD+177.22%
1.02 MAUD-39.07%
1.68 MAUD+37.51%
1.22 MAUD-50.71%
2.48 MAUD+439.65%
459,000.00AUD-93.43%
6.99 MAUD-25.78%
9.42 MAUD-28.26%
13.13 MAUD+52.79%
8.59 MAUD+29.83%
6.62 MAUD-54.74%
14.62 MAUD—
Access this data via the Eulerpool API

dorsaVi Stock analysis

What does dorsaVi do? The company dorsaVi Ltd is a leading company in the field of wearable technology based in Australia. The company was founded in 2000 by Andrew Ronchi, Andrew Dalziel, and Daniel Dorsch with the vision to improve people's health through the development of technologies that can measure human movement and performance. dorsaVi's business model is based on the development and marketing of wearable technology for use in medicine, rehabilitation, and sports. The company aims to develop innovative, user-friendly, and reliable devices that help users optimize their movement and performance. The products are used by professional athletes, physiotherapists, trainers, and doctors worldwide. dorsaVi's mission is to improve the health and well-being of people and prevent injuries by providing accurate and easy-to-use solutions. The company is built on three main pillars: Sports, Clinical, and Occupational. Each of these pillars has specific products and solutions to help users in different industries and application areas. In the Sports field, dorsaVi offers a wide range of products and solutions for professional athletes and trainers to optimize their performance and prevent injuries. The company's flagship product is the ViPerform system. This system allows athletes to accurately analyze and improve their movements during training or competition. It consists of wireless sensors attached to various parts of the body to capture data on movements, speed, acceleration, and force. The data is then sent to the dorsaVi app in real-time, where it can be analyzed, visualized, and interpreted. In the Clinical field, dorsaVi provides solutions for therapists and doctors to support patients in their recovery after an injury or surgery. The Sentral Clinical Movement Analysis System offered in this field is an advanced system for analyzing human movement. It allows therapists to observe and analyze movement patterns accurately to identify disruptions and weaknesses that may lead to pain or injuries. The collected data can help create individual therapy plans and accelerate recovery. In the Occupational field, dorsaVi develops solutions for companies and employees to improve their health and safety in the workplace. This includes the Sentral Wearable Movement Monitoring System. The system is a wireless and non-invasive solution that allows employers and employees to record and analyze their movement and load profiles in real-time. The collected data can help make ergonomic adjustments in the workplace to prevent injuries and illnesses. Over the years, dorsaVi has received numerous awards for its products and solutions. However, the company continues to strive to develop innovative technologies and products to help people optimize their movement and performance, increase their well-being, and maintain their long-term health. dorsaVi is one of the most popular companies on Eulerpool.

Equity Details

Analyzing dorsaVi's Equity

dorsaVi's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding dorsaVi's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating dorsaVi's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

dorsaVi's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in dorsaVi’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about dorsaVi stock

The Equity of dorsaVi is 2.84 M AUD in 2026.

The Equity of dorsaVi changed from 1.02 M AUD to 2.84 M AUD, representing a 177.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity dorsaVi since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's dorsaVi historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — dorsaVi

All Key Metrics — dorsaVi